
Ryscor Science
Inc. develops novel small-molecule synthetic reagents and methodologies
for pharmaceutical and biotechnology companies worldwide. The
company's technology is focused on biologically-biased multifunctional
boronic acids and heterocyles used in diverse and target-oriented synthesis.
These compounds enable
researchers involved in drug discovery rapid and reliable
access to target molecules.